期刊文献+

肺癌肿瘤抑制物1和Wnt-1诱导分泌蛋白3在非小细胞肺癌组织中表达及其临床意义 被引量:4

Expression Of tumor suppressor in lung cancer 1 and WISP-3 in non-small cell lung carcinoma
原文传递
导出
摘要 目的探讨肺癌肿瘤抑制物1(TSLCl)和Wnt-1诱导分泌蛋白3(WISP-3)在非小细胞肺癌(NSCLC)组织中的表达及两者与NSCLC临床特征之间的关系。方法采用免疫组织化学法检测80例NSCLC患者手术切除的癌组织和癌旁组织中TSLC1和WISP-3表达水平。结果TSLC1在NSCLC癌组织中的表达率为30.00%(24/80),明显低于在癌旁组织中表达率71.25%(57/80),两者差异有统计学意义(P〈0.01),WISP-3在NSCLC癌组织中的表达率为67.50%(54/80),明显高于在癌旁组织中表达率16.25%(13/80),两者差异有统计学意义(P〈0.01)。TSLC1表达水平与NSCLC组织学分化程度、TNM分期、淋巴结转移有关(P〈0.05),WISP-3表达水平与NSCLC组织学分化程度、TNM分期、年龄明显相关(P〈0.05)。结论TSLC1和WISP-3可能参与NSCLC的发生发展,并可能是NSCLC预后相关指标。 Objective To investigate the expression of tumor suppressor in lung cancer 1 (TSLC1) and WISP-3 in non-small cell lung carcinoma (NSCLC) , and their relation to the clinicopathological features. Methods Envision immunohistoehemieal method were used to assess the expression of TSLC1 and WISP-3 in 80 cases of human NSCLC tissues and non-cancerous adjacent lung tissues. Results The expression rate of TSLC1 in was 30.00% (24/80) in NSCLC tissues, and 71.25% (57/80) in non-cancerous adjacent lung tissues (P 〈0. 01 ) , the expression rate of WISP-3 was 67.50% (54/80) in NSCLC tissues, and 16. 25% (13/80) in non-cancerous adjacent lung tissues (P 〈 0. 01 ). the expressions of TSLC1 were related to histology grade, TNM stage and lymph node metastasis (P 〈 0. 05 ), there was a close relation between the expression of WISP-3 and histology grade, TNM stage and age ( P 〈 0. 05 ). Conclusion TSLC1 and WISP-3 may participate in the development and progression of NSCLC, and may be used to predict the prognosis of NSCLC patients.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第6期1146-1147,共2页 Chinese Journal of Experimental Surgery
关键词 肺癌肿瘤抑制物1 Wnt-1诱导分泌蛋白3 非小细胞肺癌 免疫组织化学 Tumor suppressor in lung cancer 1 WTSP-3 Non-small cell lung carcinoma Immunohistochemistry
  • 相关文献

参考文献5

二级参考文献9

共引文献15

同被引文献31

  • 1冯和林,赵亚恒,郑丽华,冯建刚.软骨肉瘤的相关分子机制研究进展[J].肿瘤防治研究,2014,41(4):416-420. 被引量:2
  • 2张水军,李文涛,周闯,赵龙拴,范正军.抑癌基因TSLC1在肝癌组织中的表达及临床意义[J].中华实验外科杂志,2007,24(2):185-186. 被引量:9
  • 3Liang QL, Wang BR, Li ZY, et al. Construction of eukaryotic expres- sion vector of TSLC1 gene. Arch Med Sci ,2011,7:579-585. 被引量:1
  • 4Rau KM, Huang CC, Chiu TJ, et al. Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Exp T-her Med ,2012,4:231-236. 被引量:1
  • 5Liang QL, Chen GQ, Li ZY,et al. Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest,2011,29: 107- 112. 被引量:1
  • 6Ito T,Shimada Y,Hashimoto Y,et al.Involvement of TSLC1 in pro-gression of esophageal squanous cell carcinoma.Cancer Res,2003,63:6320-6326. 被引量:1
  • 7Jones PA,Takai D.The role of DNA methylation in mammalian epige-netics.Science,2001,293:1068-1070. 被引量:1
  • 8Honda T,Tamura Gf Waki T,et al.Hypermethylation of the TSLC1gene promoter in primary gastric cancers and gastric cancer cell lines.Jpn J Cancer Res,2002,93:857-860. 被引量:1
  • 9Ritter J,Bielack SS.Osteosareoma.Ann Oncol,2010,21 Suppl 7:vvi320-wi325. 被引量:1
  • 10Geller DS,Gorlick R.Osteosarcoma:a review of diagnosis,manage-ment,and treatment strategies.Clin Adv Hematol Oncol,2010,8:705-718. 被引量:1

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部